leisure time -WSS

leisure time

author：hotspot 2025-09-30 17:29:18 - browse：63

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： House transparency, PBM reform bill gains bipartisan support

WSS

Amazon on where the company's health care bets are headed next

Study finds gene variants tied to breast cancer risk in Black women

What American doctors can learn from their Israeli counterparts

Reports of telehealth's death have been greatly exaggerated

Illumina names Agilent executive as new CEO

The 10 drugs up first for Medicare price negotiation

explore

leisure time

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

Crinetics acromegaly drug succeeds in late

Duchenne breakthrough therapy leaves behind pioneering families

Eyeing GLP

Sports medicine is finally prioritizing gender equality

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Medicare proposal to cover medical devices draws a mixed reaction

Reports of telehealth's death have been greatly exaggerated

Medicare details structure of new drug price negotiation program

As a primary care physician, here's how I hope to partner with AI

leisure time

'Make People Better': The CRISPR babies story you probably don't know

A rare thyroid diagnosis led to unexpected, all

Weighted lottery helped low

'Make People Better': The CRISPR babies story you probably don't know

How to fix cancer clinical trials' diversity problem

Amazon on where the company's health care bets are headed next

focus

explore

knowledge

knowledge